NECFA
GILD icon

New England Capital Financial Advisors’s Gilead Sciences GILD Stock Holding History

New England Capital Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49.2K Buy
390
+1
+0.3% +$132 0.01% 129
2026
Q1 		$54.2K Sell
389
-103
-21% -$14.4K 0.01% 128
2025
Q4 		$60.4K Buy
492
+1
+0.2% +$122 0.02% 122
2025
Q3 		$54.5K Buy
491
+1
+0.2% +$114 0.02% 125
2025
Q2 		$54.3K Buy
490
+2
+0.4% +$213 0.02% 116
2025
Q1 		$54.7K Sell
488
-139
-22% -$14.3K 0.03% 108
2024
Q4 		$57.9K Sell
627
-47
-7% -$4.23K 0.03% 109
2024
Q3 		$56.5K Buy
674
+4
+0.6% +$305 0.03% 107
2024
Q2 		$46K Buy
670
+4
+0.6% +$267 0.03% 115
2024
Q1 		$48.8K Buy
666
+3
+0.5% +$231 0.03% 112
2023
Q4 		$53.7K Buy
663
+4
+0.6% +$311 0.03% 111
2023
Q3 		$49.4K Buy
659
+3
+0.5% +$231 0.03% 111
2023
Q2 		$50.5K Buy
656
+4
+0.6% +$319 0.03% 111
2023
Q1 		$54.1K Buy
652
+3
+0.5% +$248 0.04% 110
2022
Q4 		$53.9K Buy
+649
New +$51.4K 0.04% 116

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Amundi
Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

New England Capital Financial Advisors's GILD Position: Q2 2026 in Review

New England Capital Financial Advisors increased its Gilead Sciences (GILD) stake by 0.26% in Q2 2026, buying an estimated $132 and bringing the position to 390 shares worth $49.2K. The position accounts for 0.01% of the portfolio, ranked #129.

New England Capital Financial Advisors first reported a position in GILD in Q4 2022 and has held it in 15 quarters since. The position peaked at $60.4K in Q4 2025. 1,689 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • New England Capital Financial Advisors held 390 shares of Gilead Sciences worth $49.2K as of Q2 2026.
  • New England Capital Financial Advisors bought 1 Gilead Sciences share in Q2 2026, an estimated $132.
  • Gilead Sciences made up 0.01% of New England Capital Financial Advisors's portfolio in Q2 2026, its #129 holding.
  • New England Capital Financial Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 15 quarters since.
  • New England Capital Financial Advisors's Gilead Sciences position peaked at $60.4K in Q4 2025.
  • 1,689 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.